Bizily Scott
SEC insider (Form 3/4/5 filer). CIK 0001920738. Chief Legal Officer at 4D Molecular Therapeutics, Inc. (FDMT). 29 reported Form 4/5 transactions since Sep 2024; latest on Oct 16, 2026. Located in EMERYVILLE, CA.
Companies Bizily Scott has filed insider reports for
- 4D Molecular Therapeutics, Inc. (FDMT): Officer, Chief Legal Officer
Bizily Scott
CIK: 0001920738
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
4D Molecular Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (29 total)
- Oct 16, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect1.6K shares at avg. $12.84$21K - Oct 16, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect1.6K shares at avg. $4.14$7K - Sep 16, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect1.6K shares at avg. $4.14$7K - Sep 16, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect1.6K shares at avg. $13.65$22K - Sep 1, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect584 shares at avg. $14.00$8K - Sep 1, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect584 shares at avg. $6.49$4K - Aug 17, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect1.6K shares at avg. $4.14$7K - Aug 17, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect1.6K shares at avg. $12.20$20K - Aug 13, 2026FDMT
4D Molecular Therapeutics, Inc.
SaleDirect1.6K shares at avg. $12.00$20K - Aug 13, 2026FDMT
4D Molecular Therapeutics, Inc.
ExerciseDirect1.6K shares at avg. $4.14$7K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $12.84 | $20,993 | Direct |
| Oct 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 1,635 | $4.14 | $6,769 | Direct |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 1,635 | $4.14 | $6,769 | Direct |
| Sep 16, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $13.65 | $22,318 | Direct |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 584 | $14.00 | $8,176 | Direct |
| Sep 1, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 584 | $6.49 | $3,790 | Direct |
| Aug 17, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 1,635 | $4.14 | $6,769 | Direct |
| Aug 17, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $12.20 | $19,947 | Direct |
| Aug 13, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Sale | 1,635 | $12.00 | $19,620 | Direct |
| Aug 13, 2026 | FDMT 4D Molecular Therapeutics, Inc. | Exercise | 1,635 | $4.14 | $6,769 | Direct |
1-10 of 29 transactions